113 related articles for article (PubMed ID: 8681643)
21. Carcinoembryonic antigen in sputum cytology.
Boon ME; Lindeman J; Meeuwissen AL; Otto AJ
Acta Cytol; 1982; 26(4):389-94. PubMed ID: 6957087
[TBL] [Abstract][Full Text] [Related]
22. [A clinical study on CA 15-3, CEA, SCC-Ag in patients with squamous cell carcinoma of the lung].
Moriya H; Suzuki S; Aizumi J; Kimura K; Urabe S; Higuci Y; Hoshi K
Rinsho Hoshasen; 1989 Jan; 34(1):63-6. PubMed ID: 2724610
[TBL] [Abstract][Full Text] [Related]
23. Cytodiagnostic aspects of bronchioloalveolar carcinoma manifesting with small cell morphology on respiratory specimens: a case report.
Siddaraju N; Yedlapati GK; Talukdar T; Saka VK; Padmavathy F; Basu D
Acta Cytol; 2010; 54(5 Suppl):1018-22. PubMed ID: 21053590
[TBL] [Abstract][Full Text] [Related]
24. [Lung adenocarcinoma presented with reticular pattern in which both CA19-9 and carcinoembryonic antigen( CEA) were recognized as markers].
Yoshitake S; Hayashi H; Oka T; Osada H; Kawahara M
Kyobu Geka; 2012 Sep; 65(10):894-7. PubMed ID: 22940662
[TBL] [Abstract][Full Text] [Related]
25. Bronchorrhea in bronchioloalveolar carcinoma.
Psathakis K; Bostantzoglou K; Sambaziotis D; Tsintiris K
Respiration; 2011; 82(1):54-5. PubMed ID: 21555870
[No Abstract] [Full Text] [Related]
26. The significance of CEA, CA19-9 and CA72-4 in the detection of colorectal carcinoma recurrence.
Holubec L; Topolcan O; Pikner R; Pecen L; Vaclavickova J; Wirthova M; Molacek J; Stieber P; Holdenrieder S; Sen LH; Finek J
Anticancer Res; 2000; 20(6D):5237-44. PubMed ID: 11326702
[TBL] [Abstract][Full Text] [Related]
27. Calculation of half-life of carcinoembryonic antigen after lung tumour resection: a case report.
Verhelst J; Vanden Broecke E; Van Meerbeeck J; De Backer W; Blockx P; Vermeire P
Eur Respir J; 1991 Mar; 4(3):374-6. PubMed ID: 1650709
[TBL] [Abstract][Full Text] [Related]
28. [Clinical evaluation of serum carbohydrate antigen 19-9 in carcinoma of the lung--a comparison with carcinoembryonic antigen].
Hayashibe A; Kodama T; Nishiwaki Y; Kudou H; Inoue Y; Nukariya N; Kaguraoka H; Kuroki M; Takahashi K; Nishiyama Y
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):711-5. PubMed ID: 3030198
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic value of CA 72-4, carcinoembryonic antigen, CA 15-3, and CA 19-9 assay in pleural fluid. A study of 207 patients.
Villena V; López-Encuentra A; Echave-Sustaeta J; Martín-Escribano P; Ortuño-de-Solo B; Estenoz-Alfaro J
Cancer; 1996 Aug; 78(4):736-40. PubMed ID: 8756365
[TBL] [Abstract][Full Text] [Related]
30. Inhaled indomethacin in bronchorrhea in bronchioloalveolar carcinoma: role of cyclooxygenase.
Tamaoki J; Kohri K; Isono K; Nagai A
Chest; 2000 Apr; 117(4):1213-4. PubMed ID: 10767270
[No Abstract] [Full Text] [Related]
31. Salt-wasting bronchorrhea and its mechanisms.
Dwek JH; Charytan C; Stachura I; Kaganowicz A
Arch Intern Med; 1977 Jun; 137(6):791-4. PubMed ID: 194543
[TBL] [Abstract][Full Text] [Related]
32. [Tumor markers in biliary tract cancer].
Najima M; Okusaka T
Nihon Rinsho; 2006 Jan; 64 Suppl 1():419-21. PubMed ID: 16457296
[No Abstract] [Full Text] [Related]
33. [Serum carcinoembryonic antigen (CEA) and carbohydrate antigen (CA 19-9) values in patients with pancreatic cancer or pancreatitis].
Changchine CS; Yung CY; Tzen KY
Changgeng Yi Xue Za Zhi; 1991 Mar; 14(1):32-8. PubMed ID: 2039968
[TBL] [Abstract][Full Text] [Related]
34. [Immunohistochemical study of the localization and distributional patterns of CA 19-9 and CEA in primary and metastatic nodal lesions of gastrointestinal cancer].
Deguchi H; Tabuchi Y; Saitoh Y
Gan No Rinsho; 1990 Jul; 36(8):890-4. PubMed ID: 1694901
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical localizations of CA 125, carcinoembryonic antigen, and CA 19-9 in normal and neoplastic glandular cells of the uterine cervix.
Nanbu Y; Fujii S; Konishi I; Nonogaki H; Mori T
Cancer; 1988 Dec; 62(12):2580-8. PubMed ID: 3191457
[TBL] [Abstract][Full Text] [Related]
36. [Tumor marker and its clinical significance in diagnosis of colorectal cancer].
Imai Y
Nihon Rinsho; 2003 Sep; 61 Suppl 7():193-6. PubMed ID: 14574880
[No Abstract] [Full Text] [Related]
37. [Bronchioloalveolar carcinoma producing CA19-9].
Sakai T; Tsushima T; Kimura D; Hatanaka R; Yamada Y; Fukuda I; Tachibana M
Kyobu Geka; 2011 Jun; 64(6):483-6. PubMed ID: 21682047
[TBL] [Abstract][Full Text] [Related]
38. [Diffuse bronchiolo-alveolar cell carcinoma that produced both amylase and CA19-9].
Nonogaki T; Morishita M; Shimizu N; Oguri T; Aoki S
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Apr; 35(4):426-31. PubMed ID: 9212668
[TBL] [Abstract][Full Text] [Related]
39. [Immunohistochemical analysis for cholangiocarcinoma].
Nakagoe T; Matsuo T; Kondoh M; Yamaguchi H
Nihon Rinsho; 2006 Jan; 64 Suppl 1():370-4. PubMed ID: 16457285
[No Abstract] [Full Text] [Related]
40. Comparison of serum assays for TAG-72, CA19-9 and CEA in gastrointestinal carcinoma patients.
Ohuchi N; Takahashi K; Matoba N; Sato T; Taira Y; Sakai N; Masuda M; Mori S
Jpn J Clin Oncol; 1989 Sep; 19(3):242-8. PubMed ID: 2810823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
